Cargando…
Current and developing therapeutic agents in the treatment of Chagas disease
Chagas disease must be treated in all its stages: acute, indeterminate, chronic, and initial and middle determinant chronic, due to the fact that DNA of the parasite can be demonstrated by PCR in chronic cases, where optical microscopy does not detect parasites. Nifurtimox (NF) and benznidazole (BNZ...
Autor principal: | Apt, Werner |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948934/ https://www.ncbi.nlm.nih.gov/pubmed/20957215 |
Ejemplares similares
-
Detection of Trypanosoma cruzi by PCR in adults with chronic Chagas disease treated with nifurtimox
por: Vergara, Camilo, et al.
Publicado: (2019) -
The Epidemiological Relevance of Family Study in Chagas Disease
por: Zulantay, Inés, et al.
Publicado: (2013) -
Quantification of Immunoglobulin G against Trypanosoma cruzi in Individuals with Chronic Chagas Disease Treated with Nifurtimox and Evaluated in Prolonged Follow-Up
por: Muñoz, Gabriela, et al.
Publicado: (2019) -
Quantification by real-time PCR of Trypanosoma cruzi DNA in samples of Triatoma infestans used in xenodiagnosis of chronic Chagas disease patients
por: Saavedra, Miguel, et al.
Publicado: (2016) -
Novel compounds in the treatment of lung cancer: current and developing therapeutic agents
por: Bao, Rudi, et al.
Publicado: (2011)